Showing results (221-230 of 241) with videos related to
Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacityC Curiel-Lewandrowski, K Mahnke, M Labeur, et al.The Journal of Investigative Dermatology|March 1, 1992
Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB lightR Kirnbauer, B Charvat, E Schauer, et al.The Journal of Investigative Dermatology|August 1, 1994
In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactionsA Schwarz, S Grabbe, H Riemann, et al.Clinical and Experimental Rheumatology|July 1, 1991
Efficacy of cyclosporin A in systemic sclerosisH Gisslinger, O C Burghuber, G Stacher, et al.The Journal of Clinical Investigation|July 1, 1993
The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiationU Trefzer, M Brockhaus, H Lötscher, et al.The Journal of Investigative Dermatology|April 1, 1991
Regulation of epidermal cell interleukin-6 production by UV light and corticosteroidsR Kirnbauer, A Köck, P Neuner, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell linesY Aragane, H Riemann, R S Bhardwaj, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Impaired cutaneous immune responses in Thy-1-deficient miceS Beissert, H T He, A O Hueber, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989
IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell linesR Kirnbauer, A Köck, T Schwarz, et al.The Journal of Dermatological Treatment|June 19, 2004
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitisT A Luger, M Lahfa, R Fölster-Holst, et al.Pageof 25